UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000029893
Receipt No. R000034148
Scientific Title The investigation for establishment of a new approach in palliative care using Virtual Reality
Date of disclosure of the study information 2017/11/09
Last modified on 2020/11/11 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The investigation for establishment of a new approach in palliative care using Virtual Reality
Acronym The investigation for establishment of a new approach in palliative care using Virtual Reality
Scientific Title The investigation for establishment of a new approach in palliative care using Virtual Reality
Scientific Title:Acronym The investigation for establishment of a new approach in palliative care using Virtual Reality
Region
Japan

Condition
Condition Cancer
Classification by specialty
Medicine in general Hematology and clinical oncology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 In this study, I aim to verify whether the approach using VR in palliative care has the possibility to contribute to the improvement of quality of life of end-of-life patients.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Change amount of Edmonton Symptom Assessment System score before and after VR experience
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Virtual Reality experience
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients admitted to a palliative care unit and inpatient patients intervened by palliative care team
Key exclusion criteria Visually impaired / hearing impaired patients, patients who can not evaluate mental symptoms, patients with high cognitive impairment
Target sample size 30

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kazuyuki Niki
Organization Osaka University/Ashiya Municipal Hospital
Division name Graduate School of Pharmaceutical Sciences/Department of Pharmacy
Zip code
Address Osaka, Suita, Yamadaoka1-6/Hyogo, Ashiya, Asahigaokacho 39-1
TEL 06-6879-8250
Email k-niki@phs.osaka-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Kazuyuki Niki
Organization Osaka University/Ashiya Municipal Hospital
Division name Graduate School of Pharmaceutical Sciences/Department of Pharmacy
Zip code
Address Osaka, Suita, Yamadaoka1-6/Hyogo, Ashiya, Asahigaokacho 39-1
TEL 06-6879-8250
Homepage URL
Email k-niki@phs.osaka-u.ac.jp

Sponsor
Institute Osaka University
Institute
Department

Funding Source
Organization Osaka University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 11 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 10 Month 05 Day
Date of IRB
2017 Year 11 Month 02 Day
Anticipated trial start date
2017 Year 11 Month 02 Day
Last follow-up date
2019 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 11 Month 09 Day
Last modified on
2020 Year 11 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000034148